Prothena Corp. Plc (PRTA)

9.74
NASDAQ : Health Technology
Prev Close 9.94
Day Low/High 9.62 / 10.10
52 Wk Low/High 8.63 / 15.91
Avg Volume 283.60K
Exchange NASDAQ
Shares Outstanding 39.87M
Market Cap 396.26M
EPS -3.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Prothena Announces Appointment Of Biotech Pioneer To Board Of Directors

Prothena Announces Appointment Of Biotech Pioneer To Board Of Directors

Christopher S. Henney, PhD Joins Prothena Board

Prothena Achieves Orphan Drug Status In EU For Lead Program NEOD001

Prothena Achieves Orphan Drug Status In EU For Lead Program NEOD001

Potential Treatment for Systemic Amyloidoses Also Has US Designation

Prothena Announces Addition Of Industry Veterans To Board Of Directors

Prothena Announces Addition Of Industry Veterans To Board Of Directors

Richard T. Collier and Shane Cooke Join Board of Directors

TheStreet Quant Rating: D (Sell)